½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

  • »¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

    021-54845833/15800441009

    Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

    µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹SMAD2¶à¿Ë¡¿¹Ìå

    ²úÆ·ÖÐÐÄ

    ×îвúÆ·

    • Íÿ¹SMAD2¶à¿Ë¡¿¹Ìå

      ¹æ¸ñ£º
      ¼Û¸ñ£º£¤
      • Æ·ÅÆ : ͨεÉúÎï
      • Ŀ¼ºÅ : TW22287
      • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
      • »õÆÚ : ÏÖ»õ
      • ¹æ¸ñ £º100ul/200ul/25ul
    • ÉÌÆ·ÏêÇé
    • ²Î¿¼ÎÄÏ×
    • ˵Ã÷ÊéÏÂÔØ
    • ÉÌÆ·ÆÀÂÛ0
    • Ïà¹Ø²úÆ·



    ÖÐÎÄÃû³Æ£º Íÿ¹SMAD2¶à¿Ë¡¿¹Ìå

    Ó¢ÎÄÃû³Æ£º Anti-SMAD2 (Ab-220) rabbit polyclonal antibody

    ±ð      Ãû£º JV18; MADH2; MADR2; JV18-1; hMAD-2; hSMAD2

    Ïà¹ØÀà±ð£º Ò»¿¹

    ´¢      ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â

    ËÞ      Ö÷£º Rabbit
     
    ¿¹      Ô­£º SMAD2

    ·´Ó¦ÖÖÊô£º Human, Mouse, Rat

    ±ê  ¼Ç Î Unconjugate

    ¿Ë¡ÀàÐÍ£º rabbit polyclonal

    ¼¼Êõ¹æ¸ñ

    Background:

    Transcriptional modulator activated by TGF-beta and activin type 1 receptor kinase. SMAD2 is a receptor-regulated SMAD (R-SMAD). May act as a tumor suppressor in colorectal carcinoma.

    Applications:

    WB, IHC

    Name of antibody:

    SMAD2

    Immunogen:

    Synthetic peptide of human SMAD2 (Ab-220)

    Full name:

    SMAD family member 2

    Synonyms£º

    JV18; MADH2; MADR2; JV18-1; hMAD-2; hSMAD2

    SwissProt:

    Q15796

    IHC positive control:

    Human breast carcinoma

    IHC Recommend dilution:

    50-100

    WB Predicted band size:

    52 kDa

    WB Positive control:

    293 and NIH/3T3 cells

    WB Recommended dilution:

    500-1000



    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿